Jardiance 25 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB25FE1AG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,359
Award facts
- Contract value 100% obligated
- $11,358.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,358.78 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on September 24, 2025, with an ultimate completion date of September 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, is well-positioned to fulfill this requirement as a primary supplier to the Defense Logistics Agency's Medical Supply Chain.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), which carries a ceiling value of $999,999,999.00 and extends through December 2026. The parent contract serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including support to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. Jardiance, a diabetes medication, aligns with the contractor's established portfolio of therapeutic products across multiple medical domains delivered through the DLA's pharmaceutical prime vendor program.
Quick answers
Who was awarded contract SPE2DB25FE1AG?
SPE2DB25FE1AG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FE1AG worth?
The government has obligated $11,359 on SPE2DB25FE1AG.
Is contract SPE2DB25FE1AG an order under another contract?
Yes. SPE2DB25FE1AG is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FE1AG competed?
The extent of competition for SPE2DB25FE1AG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award